› Forums › General Melanoma Community › Discovery and Treatment
- This topic has 2 replies, 2 voices, and was last updated 4 years, 2 months ago by ed williams.
- Post
-
- February 13, 2020 at 3:27 pm
I am over 3 years out from diagnosis as 3a and I am NED. In a recent appointment with my Derm he restated a point that he has been saying consistently through my surveillance, that the research indicates that regardless of when a recurrence is discovered (actively through surveillance or when symptoms appear) the standard of care is the same and the outcome will be the same. Meaning that treatment will work or it won’t.I am from Canada so I know standards of care differ by country.
Has anyone else had similar conversations/experience with members of their care team
Viewing 1 reply thread
- Replies
-
-
- February 13, 2020 at 4:39 pm
my Onc repeatedly used the phrase ‘standard of care’ which she backed up with a copy of thee NNCM Guideline v. 32019 with my Stage and treatments highlited. she explained that the treatment proposed was what any Onc would prescribe for that stage of melanoma.you can google. also https://www.aimatmelanoma.org/ has a good layman’s description of stages and treatment.
-
- February 13, 2020 at 6:53 pm
Hi there anon, I kind of like to look at the bright side of things and in the new 8th edition of staging document on page 17 (see link below) the stats would say that stage 3a patients on average 93% are alive at 5 years and 88% are alive at 10 years. Now that is pretty good stats and this is based on state of treatment from a couple of years ago before approvals of Pd-1 and targeted therapy for stage 3 folk. Go a little further and now there are trials opening for stage 2b and 2c patients see link below to keynote 716 which is available in several Canadian hospitals. https://cancerstaging.org/CSE/Physician/Documents/Melanoma%202.2.18.pdf https://clinicaltrials.gov/ct2/show/NCT03553836
-
Viewing 1 reply thread
- You must be logged in to reply to this topic.